Charlotte INIGUES

Charlotte INIGUES has a diverse work experience starting in 2014 at Pharmacie Port Haliguen, where they worked as a Pharmacy Student during the summers of 2014, 2015, and 2016. In 2016, they also worked at EFS in the Recrutement role. Starting in 2016 and continuing until 2017, Charlotte worked as a Pharmacy Student at Pharmacie Leguay. The following year, in 2017, they had an externship in the Dermatology Department at CHU de Rennes. In 2018, they worked as a Trade Marketing Assistant at Laboratoire SVR, where they were responsible for designing and implementing email campaigns, creating promotional materials, and managing an e-shop. Charlotte also had an externship in the Bacteriology Department at CHU de Rennes in 2018. From 2019 to 2022, they worked at Simon-Kucher & Partners, initially as an Associate Consultant and later as a Consultant in the Life Sciences Division. Their responsibilities included recruiting international experts, conducting phone interviews, and developing pricing and market access strategies for reimbursed drugs in various therapeutic areas and markets. Currently, Charlotte is working as a Market Access Manager at Mila, where they are responsible for implementing the global go-to-market strategy for a digital medical device, developing partnerships with pharmaceutical companies, creating a reimbursement dossier in France, and conducting competition analysis.

Charlotte INIGUES completed their education at multiple institutions. Charlotte obtained a Mastère spécialisé in Marketing Management et Digital, Health chair from ESSEC Business School in 2018-2019. Charlotte also completed a Diplôme de formation approfondie en sciences pharmaceutiques (DFASP) from Université de Rennes I between 2013 and 2019. In 2014-2015, they went on an Erasmus program at Universitat de Barcelona. Prior to that, they pursued a PACES program at Université de Rennes I from 2011 to 2013. In addition to their degrees, Charlotte INIGUES acquired several certifications throughout their academic journey, including Initial Project Management from Ahrens Herrmann Consulting GmbH in November 2021, Certificat de Synthèse Pharmaceutique from Université de Rennes I in June 2017, AFGSU 2 in May 2017, and AFGSU 1 in May 2015.